Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.044 USD | -7.17% | -7.37% | -28.46% |
May. 02 | North American Morning Briefing : Stock Futures -2- | DJ |
Apr. 25 | North American Morning Briefing : More Tech -2- | DJ |
Financials (USD)
Sales 2021 | - | Sales 2022 | - | Capitalization | 176M |
---|---|---|---|---|---|
Net income 2021 | -122M | Net income 2022 | -115M | EV / Sales 2021 | - |
Net cash position 2021 | 12.15M | Net Debt 2022 | 3.2M | EV / Sales 2022 | - |
P/E ratio 2021 |
-2.63
x | P/E ratio 2022 |
-1.23
x | Employees | 66 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 99.86% |
Latest transcript on Evelo Biosciences, Inc.
1 day | -7.17% | ||
1 week | -7.37% | ||
Current month | -11.11% | ||
1 month | +5.01% | ||
3 months | -12.87% | ||
6 months | -86.67% | ||
Current year | -28.46% |
Managers | Title | Age | Since |
---|---|---|---|
Craig Jalbert
CEO | Chief Executive Officer | 63 | Nov. 20 |
Andrea Itano
CTO | Chief Tech/Sci/R&D Officer | - | 16-12-31 |
Duncan McHale
CTO | Chief Tech/Sci/R&D Officer | 57 | 18-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Craig Jalbert
CEO | Chief Executive Officer | 63 | Nov. 20 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 0.044 | -7.17% | 6,868 |
24-05-07 | 0.0474 | -0.42% | 38,312 |
24-05-06 | 0.0476 | +9.43% | 17,955 |
24-05-03 | 0.0435 | -12.12% | 22,122 |
24-05-02 | 0.0495 | +4.21% | 10,229 |
Delayed Quote OTC Markets, May 08, 2024 at 03:32 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-28.46% | 835K | |
+2.93% | 108B | |
+7.02% | 23.46B | |
-14.60% | 21.72B | |
-7.05% | 18.64B | |
-38.55% | 17.45B | |
-8.83% | 17.19B | |
+5.51% | 13.99B | |
+37.49% | 12.53B | |
+329.39% | 8.81B |
- Stock Market
- Equities
- EVLO Stock